PICASSO Study: a Cohort Study of Patients With Metastatic Colorectal Cancer Treated With Avastin as First-line Therapy for Hepatic Metastases Considered as Potentially Resectable
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Colorectal Cancer
Both
Colorectal Cancer
Trial Information
PICASSO Study: a Cohort Study of Patients With Metastatic Colorectal Cancer Treated With Avastin as First-line Therapy for Hepatic Metastases Considered as Potentially Resectable
Inclusion Criteria:
- Adult patients, >/= 18 years of age
- Colorectal cancer with exclusively hepatic or hepatic and pulmonary metastases
- First-line treatment with Avastin for potentially resectable metastatic disease
Exclusion Criteria:
- Outright resectable disease
- Clearly inoperable disease
- Participation in a clinical trial evaluating a cytotoxic anticancer treatment and/or
an innovative therapy
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Response rate, defined as rate of patients without detectable metastases (after 1st-line treatment with or without surgery)
Outcome Time Frame:
approximately 4 years
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
France: Commission Nationale de l'Informatique et des Libertés (CNIL)
Study ID:
ML22999
NCT ID:
NCT01343901
Start Date:
September 2010
Completion Date:
September 2015
Related Keywords:
- Colorectal Cancer
- Colorectal Neoplasms
- Neoplasm Metastasis
Name | Location |
|---|
